N9-Isopropylolomoucine
N9-Isopropylolomoucine is a mitotic cyclin dependent kinase (CDK) inhibitor. N9-Isopropylolomoucine targets CCNB 1/CDK1 and can be used for cancer research[1].
Product Specifications
CAS Number
[158982-15-1]
Product Name Alternative
TAK-438 (hydrochloride),TAK-438 (free base)
UNSPSC
12352005
Hazard Statement
H302
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/n9-isopropylolomoucine.html
Purity
99.34
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
OCCNC1=NC2=C(N=CN2C(C)C)C(NCC3=CC=CC=C3)=N1
Molecular Formula
C17H22N6O
Molecular Weight
326.40
Precautions
H302
References & Citations
[1]Kerry L., et al. Biomarkers indicative of prostate cancer and treatment thereof. Patent. WO2018187478
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
